2015, Number 6
<< Back
Gac Med Mex 2015; 151 (6)
Diagnostic algorithm for von Willebrand Disease (vWD) in a Mexican population
Hernández-Juárez J, Moreno-Hernández M, Majluf-Cruz A
Language: Spanish
References: 7
Page: 828-833
PDF size: 82.07 Kb.
Text Extraction
No abstract.
REFERENCES
Diagnóstico y tratamiento de la enfermedad de von Willebrand. México: Secretaría de Salud; 2010.
Martínez-Murillo C. Guía rápida de la enfermedad de von Willebrand. ZAPRA Ediciones y Health Business Group (HGB); 2011.
Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood. 1987;69(6):1691-5.
Nichols WL, Hultin MB, James AH, et al. Guidelines. Von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung and Blood Institute (NHLBI) Expert Panel report (USA). Hemophilia. 2008;14(2):171-232.
Miller CH, Kelley L, Green D. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor. Am J Hematol. 1998;58(4):311-8.
Riddell AF, Gomez K, Millar CM, et al. Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor. Blood. 2009;114(16): 3489-96.
Schneppenheim R, Budde U. von Willebrand factor: the complex molecular genetics of a multidomain and multifunctional protein. J Thromb Haemost. 2011;9 Suppl 1:209-15.
Full text